Improved T Cell Immunity Following Neoadjuvant Chemotherapy in Ovarian Cancer

This study characterized the evolution of the peripheral immune cell function and composition across the course of standard of care platinum and taxane chemotherapy in ovarian cancer using bulk and single cell transcriptomic approaches. Serial blood samples were collected from ten patients with advanced high-grade serous ovarian cancer treated with chemotherapy. Single cell sequencing was performed on five patients' samples collected before the initiation of chemotherapy and after the third cycle of chemotherapy.]]>

Inclusion Criteria:Age > 18 years
Diagnosis of a suspected gynecological cancerDiagnosis of a gynecological cancer Diagnosed with a recurrent gynecological cancer
Exclusion Criteria:
Age < 18 years

]]>